457 related articles for article (PubMed ID: 27492531)
1. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.
Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M
Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for lower respiratory tract infections.
Liapikou A; Torres A
Expert Opin Pharmacother; 2014 Nov; 15(16):2307-18. PubMed ID: 25216725
[TBL] [Abstract][Full Text] [Related]
3. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
Lababidi N; Ofosu Kissi E; Elgaher WAM; Sigal V; Haupenthal J; Schwarz BC; Hirsch AKH; Rades T; Schneider M
J Control Release; 2019 Nov; 314():62-71. PubMed ID: 31654686
[TBL] [Abstract][Full Text] [Related]
4. Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
Islam N; Reid D
Respir Med; 2024 Jun; 227():107661. PubMed ID: 38729529
[TBL] [Abstract][Full Text] [Related]
5. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial.
Johnson K; McEvoy CE; Naqvi S; Wendt C; Reilkoff RA; Kunisaki KM; Wetherbee EE; Nelson D; Tirouvanziam R; Niewoehner DE
Int J Chron Obstruct Pulmon Dis; 2016; 11():799-807. PubMed ID: 27143871
[TBL] [Abstract][Full Text] [Related]
6. Biofilm-dependent airway infections: a role for ambroxol?
Cataldi M; Sblendorio V; Leo A; Piazza O
Pulm Pharmacol Ther; 2014 Aug; 28(2):98-108. PubMed ID: 24252805
[TBL] [Abstract][Full Text] [Related]
7. Rationale and evidence for the adjunctive use of N-acetylcysteine in multidrug-resistant infections.
Oliva A; Pallecchi L; Rossolini GM; Travaglino F; Zanatta P
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4316-4325. PubMed ID: 37203858
[TBL] [Abstract][Full Text] [Related]
8. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
Mateos-Corral D; Cutz E; Solomon M; Ratjen F
Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized Antibiotics.
Restrepo MI; Keyt H; Reyes LF
Respir Care; 2015 Jun; 60(6):762-1; discussion 771-3. PubMed ID: 26070573
[TBL] [Abstract][Full Text] [Related]
10. Activity of
Valzano F; Boncompagni SR; Micieli M; Di Maggio T; Di Pilato V; Colombini L; Santoro F; Pozzi G; Rossolini GM; Pallecchi L
Microbiol Spectr; 2022 Aug; 10(4):e0100622. PubMed ID: 35735984
[TBL] [Abstract][Full Text] [Related]
11. Combination of Cefditoren and
Llamosà M; Sempere J; Coronel P; Gimeno M; Yuste J; Domenech M
Microbiol Spectr; 2022 Dec; 10(6):e0341522. PubMed ID: 36445126
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review.
Dinicola S; De Grazia S; Carlomagno G; Pintucci JP
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2942-8. PubMed ID: 25339490
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and subtyping of biofilms present in bronchoalveolar lavage from children with protracted bacterial bronchitis or non-cystic fibrosis bronchiectasis: a cross-sectional study.
Marsh RL; Binks MJ; Smith-Vaughan HC; Janka M; Clark S; Richmond P; Chang AB; Thornton RB
Lancet Microbe; 2022 Mar; 3(3):e215-e223. PubMed ID: 35544075
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.
Albertson TE; Louie S; Chan AL
J Am Geriatr Soc; 2010 Mar; 58(3):570-9. PubMed ID: 20398122
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin.
Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
Am J Ther; 2013; 20(4):322-8. PubMed ID: 21519220
[TBL] [Abstract][Full Text] [Related]
16. Inhaled antimicrobial therapy - barriers to effective treatment.
Weers J
Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial effects of N-acetylcysteine against endodontic pathogens.
Moon JH; Choi YS; Lee HW; Heo JS; Chang SW; Lee JY
J Microbiol; 2016 Apr; 54(4):322-9. PubMed ID: 27033208
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
[TBL] [Abstract][Full Text] [Related]
20. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis.
Cazzola M; Calzetta L; Page C; Jardim J; Chuchalin AG; Rogliani P; Matera MG
Eur Respir Rev; 2015 Sep; 24(137):451-61. PubMed ID: 26324807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
